Artificial Intelligence in Drug Discovery by Simon Smith
Simon Smith
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
Categories: Technology
Listen to the last episode:
On this episode, I speak with Nick Lynch of the Pistoia Alliance ( www.pistoiaalliance.org ), a global nonprofit community of life science stakeholders that works to lower barriers to R&D innovation. A new area of strategic focus is artificial intelligence, which Nick oversees. On this episode, you'll learn challenges with AI that the Pistoia Alliance aims to address, why education and data are key to doing so, and how you can get involved. This episode is brought to you by BenchSci ( www.benchsci.com ). BenchSci uses artificial intelligence to reduce the time, uncertainty, and cost of scientific experiments. Use it to find research antibodies up to 24x faster than using PubMed or Google Scholar. Just enter a protein of interest and filter by technique, organism, tissue, or 13 other options. BenchSci returns only relevant published figures and products. It’s free for academic researchers. Learn more and sign up at www.benchsci.com .
Previous episodes
-
12 - Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus Tue, 07 Aug 2018
-
11 - Lucas Siow of ProteinQure on AI for Protein-Based Drugs Tue, 07 Aug 2018
-
10 - Regina Barzilay, AI Small Molecule Discovery and Synthesis Mon, 30 Jul 2018
-
9 - Tim Guilliams and David Brown, Healx, AI for Rare Diseases Thu, 26 Jul 2018
-
8 - John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology Wed, 18 Jul 2018
-
7 - Kristen Fortney, CEO of BioAge Labs, on AI Aging Research Tue, 10 Jul 2018
-
6 - Sam Cooper, CEO of Phenomic AI, on Automated HCS and More Thu, 28 Jun 2018
-
5 - Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology Wed, 20 Jun 2018
-
4 - Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics Mon, 11 Jun 2018
-
3 - Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype Tue, 29 May 2018
-
2 - Mauro Cozzi, Researchably, AI for Better Biomedical Search Tue, 22 May 2018
-
1 - Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping" Mon, 14 May 2018